ROA2_MOUSE - dbPTM
ROA2_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ROA2_MOUSE
UniProt AC O88569
Protein Name Heterogeneous nuclear ribonucleoproteins A2/B1
Gene Name Hnrnpa2b1
Organism Mus musculus (Mouse).
Sequence Length 353
Subcellular Localization Nucleus, nucleoplasm . Cytoplasmic granule . Secreted, exosome . Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Component of ribonucleosomes. Not found in the nucleolus. Found in exosomes follwong sumoylation.
Protein Description Heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNP particle arrangement on nascent hnRNA is non-random and sequence-dependent and serves to condense and stabilize the transcripts and minimize tangling and knotting. Packaging plays a role in various processes such as transcription, pre-mRNA processing, RNA nuclear export, subcellular location, mRNA translation and stability of mature mRNAs. Forms hnRNP particles with at least 20 other different hnRNP and heterogeneous nuclear RNA in the nucleus. Involved in transport of specific mRNAs to the cytoplasm in oligodendrocytes and neurons: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) or the A2RE11 (derivative 11 nucleotide oligonucleotide) sequence motifs present on some mRNAs, and promotes their transport to the cytoplasm (By similarity). Specifically binds single-stranded telomeric DNA sequences, protecting telomeric DNA repeat against endonuclease digestion (By similarity). Also binds other RNA molecules, such as primary miRNA (pri-miRNAs): acts as a nuclear 'reader' of the N6-methyladenosine (m6A) mark by specifically recognizing and binding a subset of nuclear m6A-containing pri-miRNAs. Binding to m6A-containing pri-miRNAs promotes pri-miRNA processing by enhancing binding of DGCR8 to pri-miRNA transcripts. Involved in miRNA sorting into exosomes following sumoylation, possibly by binding (m6A)-containing pre-miRNAs. Acts as a regulator of efficiency of mRNA splicing, possibly by binding to m6A-containing pre-mRNAs (By similarity)..
Protein Sequence MEKTLETVPLERKKREKEQFRKLFIGGLSFETTEESLRNYYEQWGKLTDCVVMRDPASKRSRGFGFVTFSSMAEVDAAMAARPHSIDGRVVEPKRAVAREESGKPGAHVTVKKLFVGGIKEDTEEHHLRDYFEEYGKIDTIEIITDRQSGKKRGFGFVTFDDHDPVDKIVLQKYHTINGHNAEVRKALSRQEMQEVQSSRSGRGGNFGFGDSRGGGGNFGPGPGSNFRGGSDGYGSGRGFGDGYNGYGGGPGGGNFGGSPGYGGGRGGYGGGGPGYGNQGGGYGGGYDNYGGGNYGSGSYNDFGNYNQQPSNYGPMKSGNFGGSRNMGGPYGGGNYGPGGSGGSGGYGGRSRY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEKTLETV
-------CCCCCCCC
12.29-
4Phosphorylation----MEKTLETVPLE
----CCCCCCCCCCH
19.2729514104
17 (in isoform 3)Phosphorylation-61.9329514104
17 (in isoform 2)Phosphorylation-61.9329514104
17UbiquitinationLERKKREKEQFRKLF
CHHHHHHHHHHHHHH
61.9327667366
22UbiquitinationREKEQFRKLFIGGLS
HHHHHHHHHHCCCCC
49.3822790023
29PhosphorylationKLFIGGLSFETTEES
HHHCCCCCCCCCHHH
25.0626239621
32PhosphorylationIGGLSFETTEESLRN
CCCCCCCCCHHHHHH
37.1826239621
33PhosphorylationGGLSFETTEESLRNY
CCCCCCCCHHHHHHH
30.4726239621
38MethylationETTEESLRNYYEQWG
CCCHHHHHHHHHHHC
38.0824129315
46AcetylationNYYEQWGKLTDCVVM
HHHHHHCCCEEEEEE
45.3022826441
46UbiquitinationNYYEQWGKLTDCVVM
HHHHHHCCCEEEEEE
45.3022790023
50S-nitrosocysteineQWGKLTDCVVMRDPA
HHCCCEEEEEECCCC
1.78-
50S-palmitoylationQWGKLTDCVVMRDPA
HHCCCEEEEEECCCC
1.7828526873
50S-nitrosylationQWGKLTDCVVMRDPA
HHCCCEEEEEECCCC
1.7824926564
59UbiquitinationVMRDPASKRSRGFGF
EECCCCCCCCCCCEE
57.4022790023
59AcetylationVMRDPASKRSRGFGF
EECCCCCCCCCCCEE
57.4068671
68PhosphorylationSRGFGFVTFSSMAEV
CCCCEEEEEHHHHHH
18.6225890499
70PhosphorylationGFGFVTFSSMAEVDA
CCEEEEEHHHHHHHH
15.1625777480
71PhosphorylationFGFVTFSSMAEVDAA
CEEEEEHHHHHHHHH
20.1625777480
85PhosphorylationAMAARPHSIDGRVVE
HHHCCCCCCCCEECC
25.6723684622
99MethylationEPKRAVAREESGKPG
CCCCHHHHHHCCCCC
41.4358857861
100UbiquitinationPKRAVAREESGKPGA
CCCHHHHHHCCCCCC
46.9427667366
102PhosphorylationRAVAREESGKPGAHV
CHHHHHHCCCCCCEE
47.5723684622
104MethylationVAREESGKPGAHVTV
HHHHHCCCCCCEEEE
49.94-
104MalonylationVAREESGKPGAHVTV
HHHHHCCCCCCEEEE
49.9426320211
104AcetylationVAREESGKPGAHVTV
HHHHHCCCCCCEEEE
49.9423806337
104UbiquitinationVAREESGKPGAHVTV
HHHHHCCCCCCEEEE
49.94-
104"N6,N6-dimethyllysine"VAREESGKPGAHVTV
HHHHHCCCCCCEEEE
49.94-
112UbiquitinationPGAHVTVKKLFVGGI
CCCEEEEEEEEECCC
34.1022790023
112AcetylationPGAHVTVKKLFVGGI
CCCEEEEEEEEECCC
34.1022826441
113AcetylationGAHVTVKKLFVGGIK
CCEEEEEEEEECCCC
42.7022826441
113UbiquitinationGAHVTVKKLFVGGIK
CCEEEEEEEEECCCC
42.7022790023
120UbiquitinationKLFVGGIKEDTEEHH
EEEECCCCCCCCHHH
53.46-
120AcetylationKLFVGGIKEDTEEHH
EEEECCCCCCCCHHH
53.4623806337
120SuccinylationKLFVGGIKEDTEEHH
EEEECCCCCCCCHHH
53.46-
120MalonylationKLFVGGIKEDTEEHH
EEEECCCCCCCCHHH
53.4626320211
123PhosphorylationVGGIKEDTEEHHLRD
ECCCCCCCCHHHHHH
44.3524899341
137UbiquitinationDYFEEYGKIDTIEII
HHHHHHCCCCEEEEE
36.19-
140PhosphorylationEEYGKIDTIEIITDR
HHHCCCCEEEEEECC
24.7929514104
145PhosphorylationIDTIEIITDRQSGKK
CCEEEEEECCCCCCC
30.6928066266
149PhosphorylationEIITDRQSGKKRGFG
EEEECCCCCCCCEEE
54.1728066266
152UbiquitinationTDRQSGKKRGFGFVT
ECCCCCCCCEEEEEE
62.3722790023
159PhosphorylationKRGFGFVTFDDHDPV
CCEEEEEEECCCCCH
21.0529514104
168UbiquitinationDDHDPVDKIVLQKYH
CCCCCHHHHHHEEEC
34.6422790023
168AcetylationDDHDPVDKIVLQKYH
CCCCCHHHHHHEEEC
34.6423806337
173UbiquitinationVDKIVLQKYHTINGH
HHHHHHEEECHHCCC
34.5322790023
173AcetylationVDKIVLQKYHTINGH
HHHHHHEEECHHCCC
34.5322826441
174PhosphorylationDKIVLQKYHTINGHN
HHHHHEEECHHCCCC
7.4025367039
176PhosphorylationIVLQKYHTINGHNAE
HHHEEECHHCCCCHH
17.0423684622
189PhosphorylationAEVRKALSRQEMQEV
HHHHHHHCHHHHHHH
36.4629176673
198PhosphorylationQEMQEVQSSRSGRGG
HHHHHHHHHCCCCCC
32.6624899341
199PhosphorylationEMQEVQSSRSGRGGN
HHHHHHHHCCCCCCC
17.2427742792
200MethylationMQEVQSSRSGRGGNF
HHHHHHHCCCCCCCC
48.6758857851
201PhosphorylationQEVQSSRSGRGGNFG
HHHHHHCCCCCCCCC
34.4922324799
203Asymmetric dimethylarginineVQSSRSGRGGNFGFG
HHHHCCCCCCCCCCC
51.60-
203MethylationVQSSRSGRGGNFGFG
HHHHCCCCCCCCCCC
51.6024129315
212PhosphorylationGNFGFGDSRGGGGNF
CCCCCCCCCCCCCCC
32.9523684622
213Asymmetric dimethylarginineNFGFGDSRGGGGNFG
CCCCCCCCCCCCCCC
53.14-
213MethylationNFGFGDSRGGGGNFG
CCCCCCCCCCCCCCC
53.1424129315
225PhosphorylationNFGPGPGSNFRGGSD
CCCCCCCCCCCCCCC
35.6126824392
228MethylationPGPGSNFRGGSDGYG
CCCCCCCCCCCCCCC
53.4624129315
231PhosphorylationGSNFRGGSDGYGSGR
CCCCCCCCCCCCCCC
30.5923684622
234PhosphorylationFRGGSDGYGSGRGFG
CCCCCCCCCCCCCCC
17.0726160508
236PhosphorylationGGSDGYGSGRGFGDG
CCCCCCCCCCCCCCC
19.4826160508
238MethylationSDGYGSGRGFGDGYN
CCCCCCCCCCCCCCC
38.6824129315
244PhosphorylationGRGFGDGYNGYGGGP
CCCCCCCCCCCCCCC
15.3425619855
245 (in isoform 3)Phosphorylation-42.62-
247PhosphorylationFGDGYNGYGGGPGGG
CCCCCCCCCCCCCCC
14.6825619855
259PhosphorylationGGGNFGGSPGYGGGR
CCCCCCCCCCCCCCC
18.6127087446
262PhosphorylationNFGGSPGYGGGRGGY
CCCCCCCCCCCCCCC
18.9125619855
266MethylationSPGYGGGRGGYGGGG
CCCCCCCCCCCCCCC
38.3424129315
266Asymmetric dimethylarginineSPGYGGGRGGYGGGG
CCCCCCCCCCCCCCC
38.34-
306PhosphorylationSYNDFGNYNQQPSNY
CCCCCCCCCCCCCCC
18.09-
312 (in isoform 2)Phosphorylation-53.0819144319
318PhosphorylationSNYGPMKSGNFGGSR
CCCCCCCCCCCCCCC
32.4926643407
324PhosphorylationKSGNFGGSRNMGGPY
CCCCCCCCCCCCCCC
22.3619144319
325MethylationSGNFGGSRNMGGPYG
CCCCCCCCCCCCCCC
40.1924129315
331PhosphorylationSRNMGGPYGGGNYGP
CCCCCCCCCCCCCCC
31.5125619855
336PhosphorylationGPYGGGNYGPGGSGG
CCCCCCCCCCCCCCC
28.1525619855
341PhosphorylationGNYGPGGSGGSGGYG
CCCCCCCCCCCCCCC
45.9925521595
344PhosphorylationGPGGSGGSGGYGGRS
CCCCCCCCCCCCCCC
32.3523684622
347PhosphorylationGSGGSGGYGGRSRY-
CCCCCCCCCCCCCC-
21.6727149854
350MethylationGSGGYGGRSRY----
CCCCCCCCCCC----
17.3824129315
351PhosphorylationSGGYGGRSRY-----
CCCCCCCCCC-----
38.9222705319
352MethylationGGYGGRSRY------
CCCCCCCCC------
39.5618966523
353PhosphorylationGYGGRSRY-------
CCCCCCCC-------
24.9326643407

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ROA2_MOUSE !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
266RMethylation

24129315
266RMethylation

24129315

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ROA2_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SET_MOUSESetphysical
16170352
PP2AA_MOUSEPpp2caphysical
16170352

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ROA2_MOUSE

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"The phagosomal proteome in interferon-gamma-activated macrophages.";
Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.;
Immunity 30:143-154(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324, AND MASSSPECTROMETRY.
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry.";
Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.;
J. Proteome Res. 7:5314-5326(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND MASSSPECTROMETRY.
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis.";
Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
J. Proteome Res. 7:3957-3967(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-259, AND MASSSPECTROMETRY.

TOP